| RBLX |
Roblox Corp |
Lee Anthony P |
|
2026-01-02 |
S - D |
1,583 |
80.22 |
126,992.06 |
257,872 |
| RBLX |
Roblox Corp |
Lee Anthony P |
|
2026-01-02 |
S - D |
614 |
81.52 |
50,054.02 |
257,258 |
| ARE |
ALEXANDRIA REAL ESTATE EQUITIES, INC. |
Lee Orraparn C. |
Officer
|
2026-01-02 |
A - A |
3,070 |
0.00 |
0.00 |
49,464 |
| CZR |
Caesars Entertainment, Inc. |
Lepori Stephanie |
Officer
|
2026-01-02 |
F - D |
2,196 |
23.56 |
51,737.76 |
66,548 |
| CMPX |
Compass Therapeutics, Inc. |
Lerner Neil |
Officer
|
2026-01-02 |
A - A |
62,500 |
5.17 |
323,125.00 |
382,500 |
| CMPX |
Compass Therapeutics, Inc. |
Lerner Neil |
Officer
|
2026-01-02 |
A - A |
435,000 |
0.00 |
0.00 |
435,000 |
| IPWR |
Ideal Power Inc. |
Lesster Laban E |
Director
|
2026-01-02 |
A - A |
18,182 |
0.00 |
0.00 |
42,166 |
| AOSL |
ALPHA & OMEGA SEMICONDUCTOR Ltd |
Li Wenjun |
Officer
|
2026-01-02 |
F - D |
3,157 |
20.66 |
65,223.62 |
72,165 |
| VKTX |
Viking Therapeutics, Inc. |
Lian Brian |
|
2026-01-02 |
A - A |
78,400 |
0.00 |
0.00 |
2,508,620 |
| VKTX |
Viking Therapeutics, Inc. |
Lian Brian |
|
2026-01-02 |
A - A |
224,080 |
0.00 |
0.00 |
2,732,700 |
| VKTX |
Viking Therapeutics, Inc. |
Lian Brian |
|
2026-01-02 |
A - A |
176,300 |
0.00 |
0.00 |
176,300 |
| AOSL |
ALPHA & OMEGA SEMICONDUCTOR Ltd |
Liang Yifan |
Officer
|
2026-01-02 |
F - D |
8,627 |
20.66 |
178,233.82 |
271,644 |
| MFA |
MFA FINANCIAL, INC. |
Lin Mei |
Officer
|
2026-01-02 |
A - A |
6,296 |
0.00 |
0.00 |
47,140 |
| MFA |
MFA FINANCIAL, INC. |
Lin Mei |
Officer
|
2026-01-02 |
A - A |
9,750 |
0.00 |
0.00 |
56,890 |
| EME |
EMCOR Group, Inc. |
Lind Robert Peter |
Officer
|
2026-01-02 |
A - A |
327 |
0.00 |
0.00 |
5,124 |
| LPCN |
Lipocine Inc. |
Patel Mahesh V. |
Director
Officer
|
2026-01-02 |
A - A |
25,000 |
8.00 |
200,000.00 |
182,668 |
| ATHA |
Athira Pharma, Inc. |
Litton Mark James |
|
2026-01-02 |
S - D |
2,586 |
6.88 |
17,791.68 |
40,828 |
| ACRS |
Aclaris Therapeutics, Inc. |
Loerop James |
|
2026-01-02 |
M - A |
18,150 |
0.00 |
0.00 |
161,212 |
| ACRS |
Aclaris Therapeutics, Inc. |
Loerop James |
|
2026-01-02 |
F - D |
6,171 |
2.88 |
17,772.48 |
155,041 |
| ACRS |
Aclaris Therapeutics, Inc. |
Loerop James |
|
2026-01-02 |
M - D |
18,150 |
0.00 |
0.00 |
18,700 |
| DUOT |
DUOS TECHNOLOGIES GROUP, INC. |
Lonegro Frank A |
Director
|
2026-01-02 |
A - A |
10,000 |
10.80 |
108,000.00 |
34,811 |
| SPRY |
ARS Pharmaceuticals, Inc. |
Lowenthal Richard E |
|
2026-01-02 |
A - A |
875,000 |
0.00 |
0.00 |
875,000 |
| SPRY |
ARS Pharmaceuticals, Inc. |
Lowenthal Richard E |
|
2026-01-02 |
A - A |
240,000 |
0.00 |
0.00 |
240,000 |
| THFF |
FIRST FINANCIAL CORP /IN/ |
Lowery Norman D |
|
2026-01-02 |
F - D |
2,700 |
60.42 |
163,134.00 |
37,959 |
| UNP |
UNION PACIFIC CORP |
Lute Jane H |
Director
|
2026-01-02 |
A - A |
412 |
231.91 |
95,546.92 |
11,688 |